A mechanism for enhancing tumor immunogenicity was investigated by infecting TAP1-deficient mouse lung carcinoma cells with a nonreplicating adenovirus expressing the human TAP1 gene (AdhTAP1). This evidence concerns the gene TAP1 and neoplasm.